Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract m...
The agreement will see MEDiC’s MCAT platform identify biomarkers to support the ...
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last...
Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authori...
Despite this setback, Transgene plans to explore the potential benefits of the v...
Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit a...
digital twins can be used to progress healthcare, drug development, and research...
Trends in gene therapy approvals in recent years are rapidly shaping the future ...
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen...
Starboard has accused Pfizer of “coercive conduct” after executives who initiall...
Booster Therapeutics has announced its inception to develop a new class of prote...
KeyBioscience and Eli Lilly have extended their partnership to develop a new cla...
High-concentration monoclonal antibodies (mAbs) are gaining prominence given the...
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for ...
